Get started

CLOV

Clover - To buy a stem dip.Clover Health - Intraday - We look to Buy at 2.01 (stop at 1.89) Support is located at 2.00 and should stem dips to this area. Trading close to the psychological 2.00 level. 2.00 continues to hold back the bears. We are trading at oversold extremes. We look for a temporary move lower. We look to buy dips. Our profit targets will be 2.37 and 2.47 Resistance: 2.50 / 2.65 / 2.80 Support: 2.35 / 2.20 / 2.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis , like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis , as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:CLOVLong
by Saxo
CLOV - SPACs are dead, but could this come back as a zombie? I like how well the range has been last few weeks. Despite huge sell-off in the growth names, this one has found bids. Personally, I am not a big fan of microcaps, but this one has my attention because of the business. Insurance names have reported big ERs and look strong. This is a new company trying to carve a niche in that space. Chart is setting up head and shoulder pattern. Breakdown below 1.97 could be ugly, yet volume profile doesn't indicate imminent breakdown. No reason to be bagholder by buying here. Watch for fake breakdown pattern before jumping in.
NASDAQ:CLOVLong
by CheelooTrader
Hold the line ($2)Clover Health Short Term We look to Buy at 2.10 (stop at 1.93) A higher correction is expected. 2.00 has been pivotal. Although the anticipated move higher is corrective, it does offer ample risk/reward today. We therefore, prefer to fade into the dip with a tight stop in anticipation of a move back higher. Our profit targets will be 2.65 and 2.95 Resistance: 2.90 / 3.25 / 3.90 Support: 2.00 / 1.50 / 1.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis , like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis , as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:CLOVLong
by Saxo
Clover Health Investments losing vigor. CLOVZigzag again with more drops on the cards for this one. Somewhere at the End of Wave C on this one. Confirms inplace means risk hedging, yet lower margins on profit per trade. This is likely to be the case here as well. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
NASDAQ:CLOVShort
by Rykin_Capital
3
DWAC Epic Market On Close VolatilityInto the final minutes, $DWAC was trading at $39 a share at about 3:58pm. It then flushed to $36.69 by 3:59 only to reverse and close at $42.29 by 4pm. It hit a high of $59.39 before closing at $55.40 after hours. This is off of news that they have reached a fundraising target. With Jack gone and the recent distribution in names like $TWTR and $FB, is this a rotation into a competitor? Or is it a rotation from meme stocks such as $GME, $AMC, $CLOV, $BB, and $BBBY that have recently rolled over? Either way, this is nothing short of epic volatility.
D
by aaronbasile
Wall Street Bets runs out of Steam or changed Behavior?In this article, I want to evaluate the top 12 mentioned wall street bets' (WSB) plays, because I noticed some changes in the WSB's behavior. It is interesting that 10 out of the top 12 mentioned tickers are trading in the red zone(they are negative today) and a significant decrease in volume is obvious. Only Rocketlab and BBIG are positive today..! This is for the first time in the past few months I monitor their activity that I see something like this. This could have several reasons: 1- They are cashing out of the market because of an imminent market correction..! 2- They have hurt very badly in yesterday's flash crash in the crypto market.(I like this one) 3- Newbies Do not buy their plays anymore! (least likely) What do you think about this phenomenon??? Rank: -1 NASDAQ:CLOV 2- AMEX:SPY 3- NYSE:GME 4- NYSE:AMC 5- NASDAQ:AAPL 6- NYSE:CCJ 7- BABA 8- NASDAQ:TSLA 9- NASDAQ:RKLB 10- NASDAQ:BBIG 11- NYSE:NIO 12- NASDAQ:MVST Moshkelgosha DISCLAIMER I’m not a certified financial planner/advisor nor a certified financial analyst nor an economist nor a CPA nor an accountant nor a lawyer. I’m not a finance professional through formal education. The contents on this site are for informational purposes only and do not constitute financial, accounting, or legal advice. I can’t promise that the information shared on my posts is appropriate for you or anyone else. By using this site, you agree to hold me harmless from any ramifications, financial or otherwise, that occur to you as a result of acting on information found on this site.
NASDAQ:AAPLShort
by Moshkelgosha
A Non-Random Pattern..!Jim Simons: we should try to trade patterns that happen on a non-random basis..! Now with higher confidence, we can say Wall Street bets are predictable..! NYSE:AMC with a 22 billion market cap gained more than 20% in a single day! Today's price*volume: 9.9billion second to BABA and 10% above Tesla..! Why this is important? because the last time this phenomenon happened it was the start of a Gamma squeeze..! I will not surprise to see it ranked first tomorrow! To learn more about it please read my previous post: August 23-24, 2021: Max Pain or Short squeeze? Is there hidden rationality beyond irrationality? Short Squeeze or Gamma Squeeze that is the question? August 20, 2021: This is called WSB effect..! In the past few days, I published posts about Wall Street Bets and how they conquered the market! They are not just a group of "Apes" unlike what many think, there is a master puppeteer and a core behind this phenomenon who know market mechanics top to down, the power of social media, data analysis. The master puppeteer has learned to survive in life and career with a false identity many years ago from his grandmaster..! To wrap it up, do not take an opposite position this could last for a while..! Today was the largest gain and trading volume since last "Quadruple Witching" June 18, 2021..!
NYSE:AMCLong
by Moshkelgosha
15
CLOV - A case study in the meme market’s Epileptic SqueezuresThe brief summary of data: CLOV option open interest on 8/20 (the number of contracts open for calls/puts) is absolutely enormous. For perspective, this Friday has a typical number of contracts for the stock. We see 77,006 calls and 31,986 puts (0.42 ratio) expiring, 8/13. FRIDAY 08/20 HOWEVER, we have jaw dropping 306,424 calls, and 72,752 puts (0.24 ratio). This puts us right on track for a GAMMA SQUEEZE (details further down). Earnings report showed a surprise beat on revenue (+100%), critical for growth stocks. We are at a local minimum value on the stock, so with a great earnings report, investors are eager to buy the stock. We saw this on 08/12 after earnings with the insane amount of volume (147.4million, vs the avg. of 29.22 million) fighting for the price around $9 a share. These factors, plus 25% short interest (who doesn't love hearing that), mean that CLOV is ripe for a major mind melting squeeze beginning the week of the Futures contract rollover dates beginning on the Futures First Notice Day, August 26. The futures contracts are a key piece of this meme stock puzzle that many have been trying to solve. This will likely peak before Sept. 9 due to futures rollover dates. Unless we see insane price action reaching margin call levels, which considering the DTCC's updated Uncleared Margin Rules (phase 5) going into effect on Sept 1st. is expected to cause a spike in margin calls.
NASDAQ:CLOVLong
by ChemaKyle
5
Chamath Just turn the pump on..!Feb 5th, 2021: Chamath Palihapitiya-backed Clover Health Investments said Friday it received a notice of investigation from the Securities and Exchange Commission and that it intends to cooperate. Clover, however, pushed back against a critical report from short-selling specialist Hindenburg Research, saying some claims in the report were “completely untrue.” On Thursday, Hindenburg published a scathing report that called Clover Health a “broken business,” sending the insurance firm’s shares down more than 12%, their biggest daily percentage drop in four months. Shares of Clover rose more than 3.5% in premarket trading Friday after the company published its response. Hindenburg, which has a history of publishing short-selling research, said Thursday it does not hold a position in Clover. Clover is ranked 5 at WSB..! This time I developed my method to recognize their moves at the earliest stage..! Even before it starts..! Reference Article: www.cnbc.com
NASDAQ:CLOV
by Moshkelgosha
4